Accustem Sciences (Accustem Sciences) Scaled Net Operating Assets : -19.62 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Accustem Sciences Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Accustem Sciences's operating assets for the quarter that ended in Mar. 2024 was $0.04 Mil. Accustem Sciences's operating liabilities for the quarter that ended in Mar. 2024 was $2.67 Mil. Accustem Sciences's Total Assets for the quarter that ended in Dec. 2023 was $0.13 Mil. Therefore, Accustem Sciences's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was -19.62.

Accustem Sciences Scaled Net Operating Assets Historical Data

The historical data trend for Accustem Sciences's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accustem Sciences Scaled Net Operating Assets Chart

Accustem Sciences Annual Data

Trend

Dec22

Dec23

Scaled Net Operating Assets

-0.82

-2.21

Accustem Sciences Quarterly Data
	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Scaled Net Operating Assets	Get a 7-Day Free Trial				-1.20	-4.55	-4.02	-8.05	-19.62

Competitive Comparison of Accustem Sciences's Scaled Net Operating Assets

For the Biotechnology subindustry, Accustem Sciences's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Accustem Sciences's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Accustem Sciences's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Accustem Sciences's Scaled Net Operating Assets falls into.

Accustem Sciences Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Accustem Sciences's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(0.113	-	2.189)	/	0.94
=	-2.21

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	0.134	-	0.021
=	0.113

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	2.245	-	0	-	0.056
=	2.189

Accustem Sciences's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Mar. 2024 )
=	(Operating Assets (Q: Mar. 2024 )	-	Operating Liabilities (Q: Mar. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(0.042	-	2.671)	/	0.134
=	-19.62

where

	Operating Assets		(Q: Mar. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	0.051	-	0.009
=	0.042

	Operating Liabilities		(Q: Mar. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	2.671	-	0	-	0
=	2.671

Accustem Sciences Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Accustem Sciences's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Accustem Sciences (Accustem Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Accustem Sciences Inc (OTCPK:ACUT) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

5 Penn Plaza, Suite 1954, Floor 19, New York, NY, USA, 10001

Website

http://www.accustem.com

Accustem Sciences Inc is a life sciences company dedicated to optimizing outcomes for all patients with cancer across the globe. The company takes a holistic view of its role in oncology to empower patients and care team with critical answers and tools and drive innovation in healthcare.